Amendment #1016 to H4400

Prostate Cancer Research

Representatives Cassidy of Brockton, Cronin of Easton, Ashe of Longmeadow, Barrett of North Adams, Benson of Lunenburg, Cahill of Lynn, Chan of Quincy, Crocker of Barnstable, Cutler of Duxbury, D'Emilia of Bridgewater, Day of Stoneham, Decker of Cambridge, DiZoglio of Methuen, DuBois of Brockton, Dykema of Holliston, Fernandes of Falmouth, Fiola of Fall River, Galvin of Canton, Garballey of Arlington, Garlick of Needham, Gentile of Sudbury, Gifford of Wareham, Golden of Lowell, Gordon of Bedford, Hecht of Watertown, Honan of Boston, Jones of North Reading, Kafka of Stoughton, Khan of Newton, Koczera of New Bedford, Linsky of Natick, Madaro of Boston, Mahoney of Worcester, Markey of Dartmouth, McMurtry of Dedham, Mom of Lowell, Moran of Lawrence, Moran of Boston, Muradian of Grafton, Muratore of Plymouth, Murray of Milford, O'Day of West Boylston, Orrall of Lakeville, Peake of Provincetown, Provost of Somerville, Puppolo of Springfield, Rogers of Cambridge, Roy of Franklin, Smizik of Brookline, Stanley of Waltham, Tosado of Springfield, Tucker of Salem, Ultrino of Malden, Vega of Holyoke, Walsh of Framingham, Walsh of Peabody and Wong of Saugus move to amend the bill in section 2, by striking out item 4590-0925, and inserting in place thereof the following item:

"4590-0925 For the costs of a prostate cancer awareness, education and research three-year program focusing on men with African-American, Hispanic or Latino heritage, family history of the disease and other men at high risk; provided, that the department of public health shall oversee and manage said program and shall grant not less than eighty-five per cent of the funds from this item to a nonprofit AdMeTech foundation-led Prostate Cancer Action Council that shall leverage existing partnerships with other state-funded nonprofit research organizations and current and past federally, state and privately funded prostate cancer programs aimed at saving lives, improving quality of life and reducing health care costs; and provided further, that funds in this item shall not revert and shall be made available through June 30, 2019……..$1,550,000”

Additional co-sponsor(s) added to Amendment #1016 to H4400

Prostate Cancer Research